UBS ASSET MANAGEMENT AMERICAS INC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 124 filers reported holding CARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$414,2960.0%84,3780.0%0.00%
Q1 2023$414,296
-54.3%
84,3780.0%0.00%
Q4 2022$906,221
-99.9%
84,378
+0.6%
0.00%
Q3 2022$784,977,000
+53.8%
83,865
+50.0%
0.00%
Q2 2022$510,541,000
-24.9%
55,9190.0%0.00%
Q1 2022$679,416,000
-0.2%
55,9190.0%0.00%
Q4 2021$681,094,000
-21.2%
55,9190.0%0.00%
Q3 2021$863,949,000
-0.3%
55,919
-7.9%
0.00%
Q2 2021$866,802,000
-34.1%
60,743
+0.3%
0.00%
-100.0%
Q1 2021$1,315,322,000
+45.9%
60,586
+1.7%
0.00%
Q4 2020$901,430,000
+18.9%
59,5790.0%0.00%
Q3 2020$758,142,000
+27.0%
59,579
+70.6%
0.00%
Q2 2020$597,013,000
+42.4%
34,913
+10.0%
0.00%
Q1 2020$419,139,000
-22.9%
31,729
-6.0%
0.00%
Q4 2019$543,938,000
-7.2%
33,764
+5.3%
0.00%
Q3 2019$586,003,000
+63.6%
32,057
+92.4%
0.00%
Q2 2019$358,190,000
-36.2%
16,660
-41.7%
0.00%
Q1 2019$561,114,000
+234.9%
28,599
+121.9%
0.00%
Q4 2018$167,544,000
-66.8%
12,888
-38.9%
0.00%
Q3 2018$505,345,000
+25.1%
21,1000.0%0.00%
Q2 2018$404,065,000
-79.3%
21,100
-85.2%
0.00%
-100.0%
Q3 2017$1,952,386,000
-11.0%
142,6140.0%0.00%0.0%
Q2 2017$2,194,829,000
-58.2%
142,614
-50.1%
0.00%
-60.0%
Q1 2017$5,250,897,000
+7837059.7%
285,530
+2543.8%
0.01%
Q1 2016$67,000
-63.2%
10,8000.0%0.00%
Q4 2015$182,00010,8000.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 2,799,058$42,350,00022.29%
Chescapmanager LLC 1,314,603$19,890,0002.42%
Prosight Management, LP 294,041$4,449,0002.06%
DAFNA Capital Management LLC 261,442$3,956,0001.18%
Cypress Capital Management LLC (WY) 81,269$1,230,0001.06%
KINGDON CAPITAL MANAGEMENT, L.L.C. 626,583$9,480,0001.02%
Carmignac Gestion 1,851,443$28,012,0000.29%
FARALLON CAPITAL MANAGEMENT LLC 2,465,000$37,295,0000.22%
DISCIPLINED GROWTH INVESTORS INC /MN 689,899$10,438,0000.20%
Ikarian Capital, LLC 301,700$4,565,0000.20%
View complete list of CARA THERAPEUTICS INC shareholders